#biotech

An AI model identified colon cancer on routine non‑contrast CT scans with 88% sensitivity in 18,000 patients. Radiologists seldom examine colon tissue during trauma scans. Integrating automated screening into existing pipelines detects tumors years earlier.

The Allen Institute, UW, and Fred Hutch launched a $95M open-science initiative to train AI in cell biology. Closed commercial biology APIs lock drug designs behind paywalls. Open biological models let research teams build and test molecular medicines without licensing fees.

Insilico Medicine reached nine-figure revenue from AI-designed drug molecules in human clinical trials. Traditional drug discovery takes five years and $500M of lab screening. Generative molecular models produce viable clinical candidates in under 12 months at 80% lower cost.